An ELISA system for the human glycosylation inhibiting factor (GIF) was established using polyclonal antibodies against highly purified 13 kDa recombinant human GIF, and the concentration of GIF in the sera of healthy donors and patients with various diseases was determined. GIF was detected in the sera of most healthy individuals and its concentration tended to increase with age. It was also found that the serum GIF levels markedly increased in some patients with rheumatoid arthritis or malignant tumors. Analysis of serum samples by SDS-PAGE and immunoblotting revealed a 55 kDa protein that has both the GIF antigenic determinant and the TCR α chain determinant. A 13 kDa GIF was not detected in the sera. In view of our previous findings on antigen-specific GIF from murine suppressor T cell hybridomas indicating that the 55 kDa GIF is a post-translationaly formed conjugate of a TCR α chain with 13 kDa GIF, we suspect that the 55 kDa GIF detected in human sera is a human homologue of the murine 55 kDa GIF.
Introduction
In the course of previous studies on regulation of the IgE supernatants of some human T cell hybridomas specific for bee venom phospholipase A 2 (6). Upon stimulation with an antibody response in the mouse, we have described glycosylation inhibiting factor (GIF), a 13 kDa cytokine that is involved anti-TCR αβ antibody, some of the GIF-producing T cell hybridomas released GIF having affinity for the specific in the selective formation of IgE-suppressive factors (1). It was found that GIF inhibited N-glycosylation of IgE-binding antigen. However, the antigen-specific human GIF has not been biochemically identified. Molecular cloning of murine factors and that the unglycosylated IgE-binding factors selectively suppressed IgE synthesis. The major cell source of GIF and human GIF indicated that GIF of both species are 13 kDa peptides of 115 amino acids, and that human GIF has is antigen-specific suppressor T (T s ) cells (2). It was also found that antigenic stimulation of murine T s hybridomas 90% homology with murine GIF at the amino acid level (7). Unexpectedly, various cell lines, including Th hybridomas resulted in the formation of GIF having affinity for the specific antigen and that the antigen-specific GIF represented an and B cell lines, contained mRNA that hybridized with GIF cDNA, and culture supernatants of these cell line cells conantigen-specific T s factor (TsF) (3). In an attempt to biochemically identify the antigen-specific GIF from ovalbumin (OVA)-tained a 13 kDa peptide that bound anti-GIF in immunoblotting. However, the peptide from these cell line cells lacked bioactivspecific T s hybridoma and homologous transfectants of TCR α chain cDNA in the T s hybridoma, we identified a 55 kDa ity, and only the peptide from T s hybridomas had the activity (8). Recombinant GIF expressed in Escherichia coli and protein that is a subunit of TsF, and has both the GIF antigenic determinant and TCR α chain determinant (4,5). Evidence was COS1 cells were also inactive (7). Since the nucleotide sequence of the GIF cDNA from the T h hybridomas and also obtained that the 55 kDa protein is a post-translationally formed conjugate of the TCR α chain with the 13 kDa GIF.
B cell lines was identical to the GIF cDNA from T s cells, we speculated that the bioactivity of GIF peptides was generated Bioactive 13 kDa human GIF has been detected in culture by post-translational modifications of the peptide in T s cells room temperature. TMB solution (Dako, Carpinteria, CA) was added to each well to develop the ELISA signals and after (8). Indeed, more recent studies have provided evidence that cysteinylation of Cys60 in the inactive GIF, which causes incubation for 30 min at room temperature, 1 N HCl/3 N H 2 SO 4 was added to each well to stop the reaction. ELISA conformational changes in the GIF molecules, is responsible for the generation of bioactive GIF (9,10). signals were determined by absorption at 450 nm and GIF concentration was calculated from a standard curve drawn In the present study, we obtained polyclonal antibodies against E. coli.-derived recombinant human GIF and estabby using rhGIF of known concentrations. lished an ELISA system for the detection of GIF in human Subjects sera. The results show that a measurable quantity of GIF is present in most human sera, and indicate that serum GIF in
The subjects employed in this study were 362 healthy donors (71 males and homes and laboratories, and most of the aged subjects (over described (9). Recombinant hGIF was purified from a soluble 70 years old) were residents of old-age homes. All healthy fraction of the cells by the use of a CM-Sepharose Fast Flow donors were free of acute infection and immunological dis-(Pharmacia Biotech, Uppsala, Sweden) column with an NaCl eases. Many of the aged subjects were receiving medication step gradient and purified GIF was isolated by HPLC on a for hypertension, hyperlipidemia, sleeplessness, osteoporosis CM-5PW column with an NaCl linear gradient, followed by or angina pectoris. Among the 26 patients with allergic gel filtration on a Superdex 75 (Pharmacia Biotech) column diseases, 14 suffered from allergic rhinitis, 13 suffered from (11). The final GIF preparation gave a single 13 kDa band in allergic dermatitis and six suffered from bronchial asthma SDS-PAGE analysis.
(some patients had two or more symptoms.). Diagnosis of Rabbits were immunized by i.m. injection of 100 µg of rheumatoid arthritis was made using the 1987 criteria of the rhGIF peptide included in complete Freund's adjuvant, the American College of Rheumatology (12). Patients were followed by seven booster injections of the peptide with clinically active and did not meet the criteria for clinical incomplete Freund's adjuvant. The IgG fraction of the antiremission of rheumatoid arthritis (13) . The mean duration of serum was employed to detect GIF by ELISA. The fraction the disease was 6 years Ϯ 1 month (range, 3 months to was biotinylated using sulfosuccinimidyl N-(D-biotinyl)-6-28 years). To assess the radiological bone damage in the aminohexanoate (Dojindo, Kumamoto, Japan) following the patients with rheumatoid arthritis, Larsen's damage score, manufacturer's protocol.
which indicates the degree of bone erosion of 20 joints of the Anti-human TCR α antibody (H-20) was purchased from fingers, was employed (14). The rates of progression in Santa Cruz Biotechnology (Santa Cruz, CA). The preparation Larsen's damage score were calculated by dividing the is affinity-purified goat polyclonal antibody raised against a difference in the damage scores obtained at two different peptide mapping at the C-terminus of TCR α of human origin.
times by the number of months between the scoring. The 39 malignant tumor cases included seven cases of stomach Measurement of the serum GIF level by ELISA cancer, four cases of lung cancer, four cases of hepatocellular carcinoma, four cases of colorectal cancer, three cases of The serum concentration of GIF was measured using a sandwich ELISA system as follows. Each well of a 96-hole multiple myeloma, two cases of malignant lymphoma, two cases of pancreas cancer, two cases of cholangiocarcinoma, microtiter plate (Maxi Sorp; Nunc, Roskilde, Denmark) was coated with 100 µl of the IgG fraction of rabbit anti-rhGIF at two cases of renal cell carcinoma, two cases of prostate cancer, one case of esophageal cancer, one case of breast 1 µg/ml in 50 mM sodium bicarbonate buffer (pH 9.0) and left overnight at 4°C. The plate was washed 4 times with PBS cancer, one case of skin cancer, one case of thyroid cancer, one case of metastatic liver cancer of unknown origin, one containing 0.05% Tween 20 (Sigma, St Louis, MO) (PBST) and the wells were rinsed with PBS. The plate was washed case of lung cancer with hepatocellular carcinoma and one case of acute leukemia. All of these cases were in the between each of the following steps. The wells were blocked with Super Block (Pierce, Rockford, IL) at 4°C overnight.
advanced stage. Serum samples were diluted 1/10 with PBS, and these samples Identification of serum GIF by immunoblotting (100 µl) were added to the wells and incubated at 4°C overnight. Recombinant hGIF diluted with PBS containing Serum GIF were analyzed by SDS-PAGE and immunoblotting. Serum samples were diluted 1/50 with PBS and 25 µl of each 0.5% BSA was used as a standard. Then, 100 µl of 0.5 µg/ml biotinylated anti-rhGIF in PBST was added and sample, mixed with the same volume of sample buffer, was electrophoresed in an 18% polyacrylamide slab gel under incubated at 4°C overnight. The plates were then incubated with 100 µl of 1/5000 dilution of horseradish peroxidase reducing conditions at 20 mA for 4-5 h. The peptides were then transferred to a PVDF membrane (Immobilon; Millipore, (HRP)-streptavidin (Zymed, San Francisco, CA) for 2 h at The insert graph shows absorption at low GIF levels (ഛ0.4 ng/ml). To confirm the specificity, a portion of the biotinylated IgG fraction of anti-GIF antiserum was Fig. 2 . Serum GIF levels in healthy donors. Serum GIF levels in absorbed with a rhGIF-coupled Sepharose column. As a detection healthy donors (362 in total) were measured by ELISA. The results antibody in ELISA, biotinylated anti-GIF (s) or the flow-through fraction were classified by age groups. The results are expressed as means of the antibody from the rhGIF-column (u) was used. Absorption at Ϯ SEM and they were analyzed using the unpaired t-test. *P Ͻ 0.01, 0 ng/ml of rhGIF was subtracted from each data, and the results are compared with age groups of 20-29 and 30-39. expressed as means Ϯ SEM.
GIF was absorbed with rhGIF-coupled HiTrap NHS-activated Sepharose and the flow-through fraction was used in place Bedford, MA). After blocking with 2% BSA in PBS for 1 h at room temperature, the membrane was incubated with of biotinylated anti-GIF antibody for the detection of rhGIF.
As shown in Fig. 1 , no increase in the ELISA signal was 1 µg/ml of the IgG fraction of anti-rhGIF antiserum in PBST at 4°C overnight. After washing, the membrane was incubated detected with the flow-through fraction. We speculated that GIF might be present in normal human with a 1/4000 dilution of HRP-conjugated anti-rabbit Ig (Amersham, Little Chalfont, UK) and HRP-streptavidin sera and measured the GIF levels in the sera of the 362 healthy adult donors. As shown in Fig. 2 , GIF was detectable (Zymed), and the specific signals were visualized using an enhanced chemiluminescence Western blot detection system in many of the normal serum samples. It was also found that the GIF level in normal serum tends to increase with advancing (Amersham).
The same method was used for the detection of peptides age. Although no significant differences were found among the 20s, 30s, 40s, and 50s age groups or among the 60s, with the TCR α chain determinant except for the use of goat polyclonal anti-human TCR α chain antibody and HRP70s, 80s and 90s age groups, GIF levels in the 20s and 30s age groups were significantly lower than those in the 60s and conjugated anti-goat Ig (Dako).
Affinity chromatography was employed to confirm the presolder age groups. ence of peptides with the TCR α chain determinant in human Increase in serum GIF levels in patients with rheumatoid serum. Affinity-purified anti-human TCR α chain antibody arthritis and those with malignant tumor was coupled to HiTrap NHS-activated Sepharose (Pharmacia Biotech) following the manufacturer's protocol. A serum Considering possible role of GIF in the regulation of IgE synthesis, we measured serum GIF levels of patients with sample (5 ml) was diluted 1/10 in PBS and applied to 1 ml of a TCR α chain-coupled column and the flow-through fraction allergic disease such as bronchial asthma, allergic rhinitis and atopic dermatitis. Sixteen cases out of 26 showed IgE was circulated at 4°C overnight through the column. After washing with a 30 column volume of PBS, proteins retained levels that exceeded the normal range and 10 cases showed IgE levels within the normal range. We also measured serum in the column were eluted with 0.1 M glycine-HCl buffer (pH 3.0). After adjusting pH to 7.0, the fraction was added with GIF levels of age-matched healthy donors. We could not obtain a significant difference between the two groups, because 21 0.1% SDS and dialyzed against PBS. The sample was then analyzed by SDS-PAGE and immunoblotting with anti-rhGIF out of 26 patients with allergic diseases and 15 out of 26 healthy donors showed lower serum GIF levels than significant antibody.
level (2 ng/ml). However, we found that the serum GIF levels had markedly Results increased in some patients with rheumatoid arthritis. Measurement of the levels of GIF in sera from 47 patients with Serum GIF levels in healthy adult donors rheumatoid arthritis indicated that the patients had significantly higher serum GIF levels (18.96 Ϯ 2.19 ng/ml) than We established a sandwich ELISA system for human GIF protein using the IgG fraction of polyclonal anti-GIF serum.
the age-matched controls of healthy individuals(4.53 Ϯ 0.53 ng/ml) (Fig. 3) . As shown in the insert of Fig. 1 , rhGIF at a concentration of 0.2 ng/ml or higher could be quantitatively measured.
Serum GIF levels in patients with rheumatoid arthritis may have some clinical significance. We therefore compared the To see the specificity of the ELISA system, biotinylated anti- GIF in human serum samples was measured by the ELISA system using biotinylated anti-GIF (Ab) or the flow-through fraction of the antibody preparation from a rhGIF column (Absorbed Ab) as a detection antibody (cf. Fig. 1).  Fig. 3 . Serum GIF levels in the patients with rheumatoid arthritis. Serum GIF levels in the 47 patients with rheumatoid arthritis were measured by ELISA and compared with those in age-matched healthy donors (n ϭ 40). The results were analyzed using the unpaired while only one of the 22 patients with a serum GIF level of t-test. *P Ͻ 0.01 compared with healthy donors. less than 10 ng/ml had metastasis.
To confirm the specificity of the measurement of GIF in the sera of patients with rheumatoid arthritis or malignant tumors, ELISA was performed on representative cases using the biotinylated IgG fraction of anti-GIF and that absorbed with rhGIF immunosorbent. The results shown in Fig. 5 indicated that the anti-GIF antibodies in the IgG fraction were responsible for giving ELISA signals in the serum samples.
Biochemical identification of serum GIF
We attempted to identify the GIF peptide in the serum samples obtained from patients with rheumatoid arthritis and those with malignant tumors by immunoblotting. Normal sera with undetectable levels of serum GIF were used as controls. Analysis of the samples by SDS-PAGE under reducing conditions and immunoblotting with anti-GIF antibody revealed a 55 kDa band, but no 13 kDa band, in the sera of patients with rheumatoid arthritis or malignant tumors (Fig. 6A) . As In view of our previous results on the products of GIFby ELISA and compared with those in age-matched healthy donors (n ϭ 50). The results were analyzed using the unpaired t-test. producing murine T cell hybridomas showing that the 55 kDa *P Ͻ 0.01 compared with healthy donors. murine GIF bound both anti-GIF antibodies and monoclonal anti-TCR α chain antibodies in immunoblotting (4,5), we investigated whether the 55 kDa GIF in the same sera has the TCR α determinant. As shown in Fig. 6B , the 55 kDa clinical features of 10 cases with high serum GIF levels (ജ25 ng/ml) and 37 cases with low serum GIF levels protein bound not only anti-GIF but also the antibodies specific for the human TCR α chain. In addition to the 55 kDa band, (ഛ25 ng/ml) (Fig. 3) . No significant difference between these two groups was found in serum CRP level, classification of a weak 27 kDa band was detected in serum samples in which the concentration of the 55 kDa GIF was relatively high functional status, radiological staging of bone damage or number of swelling joints. However, a positive correlation was (Fig. 6B) . The 27 kDa protein was usually undetectable when anti-GIF was employed for immunoblotting (cf. Fig. 6A ). In found between serum GIF level and rate of progression in Larsen's damage score (cf. Methods and H. Takahashi et al., some serum samples, however, a faint 27 kDa band was detected even with anti-GIF. The nature of the 27 kDa protein submitted).
We also measured the serum GIF concentrations in serum is unknown, but we suspect that this protein is a degraded product of the 55 kDa GIF. samples from patients with malignant tumor. As shown in Fig. 4 , the serum GIF levels in the patients with malignant
We also analyzed several serum samples obtained from healthy aged individuals by SDS-PAGE and immunoblotting. tumor were higher (13.61 Ϯ 2.93 ng/ml) than those in agematched healthy donors (5.07 Ϯ 0.56 ng/ml). Four patients In all of the serum samples with a GIF level of 10 ng/ml or higher, the 55 kDa protein with both the GIF determinant and with extremely high levels of serum GIF suffered from invasion of cancer and/or metastasis. Indeed, among the 17 patients the TCR α chain determinant was detected, but the 13 kDa GIF was not detected in any of the samples analyzed (results with a serum GIF level of 10 ng/ml or higher, 11 had metastasis, were obtained by immunization of rabbits with a highly purified recombinant GIF having a mol. wt of 12,346 (9), we anticipated that GIF detected in human sera would be the 13 kDa GIF. Unexpectedly, we detected a 55 kDa GIF protein, which also possessed the TCR α determinant, rather than 13 kDa GIF. Indeed, the 55 kDa GIF bound to the anti-TCR α chain antibody-coupled immunosorbent and could be recovered by acid elution (Fig. 7) . Considering the mol. wt of the protein, In our previous studies using murine T s hybridomas and Lanes 1 and 2, healthy donors (serum GIF level: Ͻ2 ng/ml); lanes 3 and 4, patients with rheumatoid arthritis (serum GIF levels: 69.5 and homologous transfectants of TCR α chain cDNA in the 42.5 ng/ml respectively); lanes 5, 6 and 7, patients with malignant hybridoma (4,5), which formed antigen-specific GIF upon tumors (serum GIF levels: 75, 44.5 and 63 ng/ml respectively); lane stimulation with anti-CD3, we obtained evidence that the 8, rhGIF. murine 55 kDa GIF is a subunit of antigen-specific GIF and represents a post-translationally formed conjugate of a TCR α chain with a 13 kDa GIF peptide (5). The association of both the GIF determinant and TCR α chain determinant with not shown). We did not pursue the experiments to detect the 55 kDa GIF in the serum samples containing less than the human 55 kDa GIF indicates that the human GIF protein detected in the present experiments is a human homologue 10 ng/ml GIF by ELISA, because non-specific bands appeared in immunoblotting by using a 1:20 dilution of serum of the murine 55 kDa GIF. Previous studies by Thomas et al. (6) on human GIF have samples (see Methods).
To confirm that the 55 kDa GIF in human serum binds to shown that human T s hybridomas specific for bee venom phospholipase A 2 constitutively secreted the 13 kDa GIF and anti-TCR α chain antibody, we absorbed a serum of a patient with breast cancer, that had a GIF level of 98 ng/ml, with an produced antigen-specific GIF upon stimulation with anti-CD3. The molecular size of the antigen-specific GIF was anti-TCR α chain antibody-coupled Sepharose column, and the acid eluate of the column was analyzed by SDS-PAGE estimated to be~80 kDa by gel filtration, but biochemical identification of the protein was unsuccessful (15) . Thus, the and immunoblotting with anti-GIF. As shown in Fig. 7 , the 55 kDa protein with the GIF determinant was detected in the present findings were the first demonstration of human 55 kDa GIF, which may represent a subunit of antigen-specific GIF. acid eluate, indicating that the protein possessed both the GIF antigenic determinant and the TCR α chain determinant.
Another important finding obtained in the present study is that the 55 kDa GIF is formed in vivo. It should be noted that all previous studies on the murine 55 kDa GIF were carried Discussion out using T s hybridomas and their homologous transfectants with the TCR α chain cDNA and the protein was detected in In the present study, we established a sandwich ELISA method for the measurement of GIF, and detected a protein the culture supernatant of anti-CD3-stimulated cells. The presence of the human homologue in the sera of healthy with the GIF determinant(s) in the sera of healthy aged individuals and patients with rheumatoid arthritis or malignant aged individuals suggests that the 55 kDa GIF is formed in vivo under physiological conditions. tumors. As the anti-GIF antibodies employed for the ELISA The association of the TCR α chain determinant with the aged individuals. Further studies are required for elucidation of the mechanisms involved in the formation of 55 kDa GIF human GIF indicates that the cell source of the 55 kDa GIF is probably T s cells, which bear TCR αβ. In the murine system, in vivo, and for identification of its bioactivity. the 55 kDa GIF was formed only after stimulation of the T s hybridomas with antigen-pulsed antigen-presenting cells or Abbreviations anti-CD3 (4,5), which facilitated translocation of the cytosolic APC antigen-presenting cell 13 kDa GIF into the endoplasmic reticulum (16) . When T h cell GIF glycosylation inhibiting factor clones and T h hybridomas were stimulated with anti-CD3, the HRP horseradish peroxidase translocation of inactive cytosolic GIF to subcellular organelles OVA ovalbumin did not occur and these cells failed to form the 55 kDa GIF.
TsF suppressor T cell factor
If the same principles apply to the human system, the cell source of the human 55 kDa GIF described here would be References T s cells, which constitutively secrete 13 kDa bioactive GIF.
The results of previous experiments on OVA-specific murine
